Skip to content

Comparison of the effects of ciprofol and propofol on postoperative nausea and vomiting in outpatient hysteroscopic patients

Comparison of the effects of ciprofol and propofol on postoperative nausea and vomiting in outpatient hysteroscopic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075149
Enrollment
Unknown
Registered
2023-08-28
Start date
2023-09-04
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless hysteroscopy anesthesia

Interventions

Propofol group:Propofol

Sponsors

Department of Anesthesiology,The First Affiliated Hospital of USTC
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 18 to 75 years old; 2. ASA grades I-II; 3. No previous liver or kidney dysfunction or endocrine disorders; 4. No history of hypertension, diabetes, cardiovascular and cerebrovascular diseases and other diseases; 5. No recent history of colds; 6. No history of long-term use of sedatives and analgesics.

Exclusion criteria

Exclusion criteria: 1.Severe cardiopulmonary dysfunction and recent respiratory colds.

Design outcomes

Primary

MeasureTime frame
Nausea and vomiting;

Secondary

MeasureTime frame
Time of consciousness disappearance after intravenous administration;Hysteroscopy examination time;Wake-up time;Departure time;The incidence of adverse reactions such as hypotension, respiratory depression, bradycardia, and injection pain;Heart rate;Mean arterial pressure;SpO2;

Countries

China

Contacts

Public ContactXie Yanhu

The First Affiliated Hospital of USTC

xyh200701@sina.cn+86 139 5601 3081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026